Lymphoma Study Shows Increased Malaria Risk with Rituximab Treatment
January 6, 2026
Chapel Hill, NC — Researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID), in collaboration with the UNC Lineberger Comprehensive Cancer Center, and UNC Project-Malawi, found adults receiving rituximab as part of cancer treatment face a significantly higher risk of developing symptomatic malaria in an endemic region....
